Company news
Polyrizon Ltd. news in 2024
Polyrizon Ltd.'s news releases, calls and decks from 2024, newest first.
Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies
December 29, 2024
Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs
December 18, 2024
Polyrizon's Moving Forward with Expected 2025 Clinical Trial - Entered Manufacturing Agreement for its PL-14 Allergy Blocker
December 17, 2024
Polyrizon Announces Appointment of VP of Regulatory Affairs and Quality Assurance
December 12, 2024
Polyrizon Enters into GMP Manufacturing Agreement for CTM Supply of its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
December 1, 2024
Polyrizon Announces Closing of $4.2 Million Initial Public Offering
October 29, 2024